|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.13 USD | +0.91% |
|
+5.00% | -0.89% |
| Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
| Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
Roivant Sciences Ltd. (NasdaqGS:ROIV) announces a share repurchase program. Under the program, the company will repurchase up to $1,500 million worth of its common shares. The repurchase program will be funded with available cash and cash equivalents on hand.
The program has no expiration date.
| 1st Jan change | Capi. | |
|---|---|---|
| -0.89% | 8.97B | |
| +26.47% | 664B | |
| +26.74% | 567B | |
| -6.33% | 354B | |
| +19.35% | 330B | |
| +4.23% | 286B | |
| +13.43% | 234B | |
| +4.71% | 199B | |
| -9.53% | 196B | |
| -4.04% | 148B |
ROIVANT SCIENCES LTD. 
